Results 181 to 190 of about 96,642 (272)

Primary non-response in inflammatory arthritis treated with biologics and targeted therapies in daily clinical practice. [PDF]

Ther Adv Musculoskelet Dis
Leon L, Freites-Nuñez D, Toledano E, Candelas G, Martinez C, Rodríguez-Laguna M, Fernández-Gutiérrez B, Abasolo L.   +7 more
europepmc   +1 more source

A Retrospective Analysis of PK and Response of Oral Ibuprofen in the Treatment of a Patent Ductus Arteriosus in Extremely Low Gestational Age Neonates

The Journal of Clinical Pharmacology, EarlyView.
Abstract Oral ibuprofen is the preferred pharmacotherapeutic option for treatment of a persistent patent ductus arteriosus (PDA), but evidence for its optimal use in extremely low gestational age newborns (ELGANs) remains limited. In the current study, we aimed to investigate the pharmacokinetics and exposure‐response relationship of oral ibuprofen in ...
Mohd Asif, Katelyn Sushko, Abdul Razak, Sayem Borhan, Michael Rieder, John van den Anker, Samira Samiee‐Zafarghandy   +6 more
wiley   +1 more source

A New Era in Diabetic Kidney Disease Treatment: The Four Pillars and Strategies to Build Beyond. [PDF]

Electrolyte Blood Press
Han S, Kim S.
europepmc   +1 more source

Cardiovascular disease risk in Korean patients with systemic lupus erythematosus compared to diabetes mellitus and the general population. [PDF]

Sci Rep
Han JY, Cho SK, Jeon Y, Kang G, Jung SY, Jang EJ, Sung YK.   +6 more
europepmc   +1 more source

Effect of Phenylbutazone Administration on Insulin Sensitivity in Horses With Insulin Dysregulation. [PDF]

J Vet Intern Med
Kemp KL, Yuen NKY, Skinner JE, Bertin FR.   +3 more
europepmc   +1 more source

Serum vitamin D concentration is inversely associated with matrix metalloproteinase‐9 level in periodontal diseases

Journal of Periodontology, EarlyView.
Abstract Background The aim of this study was to investigate the potential association between vitamin D deficiency and matrix metalloproteinase‐9 (MMP‐9) levels in gingival crevicular fluid (GCF) across various periodontal health and disease statuses.
Yeşim Ayhan Yıldırım, Ayla Ozturk, Fatma Doğruel, Hatice Saraçoğlu, Cevat Yazıcı   +4 more
wiley   +1 more source

Benchmarks for low back pain in general practice in Flanders: electronic audit of INTEGO. [PDF]

BMC Prim Care
Paridaens R, Vaes B, Van den Bulck S, Soetaert J.   +3 more
europepmc   +1 more source

Have we hit the JAK‐pot? Success of selective JAK 1 inhibitor following failure of pan‐JAK inhibitor in refractory pediatric ulcerative colitis

JPGN Reports, EarlyView.
Abstract The treatment options available for pediatric ulcerative colitis (UC) are challenging due to few with Federal Drug Administration approval. Newer medications approved for adults include additional biologics with differing mechanisms of action and small molecule drugs, such as Janus kinase (JAK) inhibitors.
Jessica A. Black, Brad Pasternak
wiley   +1 more source

Methotrexate-related drug reactions on kidneys and liver in rheumatoid arthritis: an analysis of spontaneous reports in EudraVigilance. [PDF]

Arthritis Res Ther
Khoroshun K, Bantel C, Hoffmann F, Jobski K.   +3 more
europepmc   +1 more source

Upadacitinib for difficult‐to‐treat paediatric Crohn's disease

JPGN Reports, EarlyView.
Abstract Paediatric‐onset inflammatory bowel disease (IBD) has an enormous impact on healthcare systems as it translates to a lifetime of healthcare. Since the approval of anti‐tumour necrosis factor‐alpha agents, it has become evident that in the long journey of paediatric IBD, there is an absolute need for more treatment options.
N. Nedelkopoulou, S. Sharma, M. Khalid, C. Hinchliffe   +3 more
wiley   +1 more source